Comprehensive safety analysis of the clinical spectrum of adverse events associated with immune checkpoint inhibitors based on FAERS
-
By
-
Caihong Qu
-
Xiaoying Wang
-
May 1, 2026
-
0 min
Top Institutions in Urology
Brief introduction explaining scope and methodology.
-
#1
The University of Texas MD Anderson Cancer Center
Houston, Texas
Key Differentiators
- Oncology
-
#2
Memorial Sloan Kettering Cancer Center
New York, New York
Key Differentiators
- Oncology
-
#3
Mass General Cancer Center
Boston, Massachusetts
Key Differentiators
- Oncology
-
#4
National Cancer Institute
Bethesda, Maryland
Key Differentiators
- Oncology
-
#5
Cleveland Clinic
Cleveland, Ohio
Key Differentiators
- Oncology
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.